Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study. [electronic resource]
Producer: 20200629Description: 1129-1148 p. digitalISSN:- 1178-2013
- Administration, Oral
- Animals
- Biological Availability
- Diabetes Mellitus, Experimental -- drug therapy
- Drug Liberation
- Fatty Acids -- chemistry
- Freeze Drying
- Gliclazide -- administration & dosage
- Hypoglycemic Agents -- administration & dosage
- Lipids -- chemistry
- Male
- Nanoparticles -- administration & dosage
- Particle Size
- Poloxamer -- chemistry
- Rats, Wistar
- Solubility
- Tablets -- chemistry
- Toxicity Tests, Subacute
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.